A subtoxic dose of CCl 4 is known to destroy liver microsomal cytochrome P-450 and this is widely accepted as the mechanism of CCl 4 autoprotection. Circumstantial evidence suggests that while cytochrome P-450 is significantly decreased, this mechanism alone cannot explain the phenomenon of autoprotection. Previous studies have established that hepatocellular regeneration is stimulated as early as 6 hr after the administration of a low dose of CC14. If the early phase stimulation of hepatocellular regeneration by the protective dose is indeed the mechanism of autoprotection, then ablation of this early phase of tissue healing by colchicine should result in an abolishment of autoprotection. Present studies were conducted to test this conceptual premise. The protection afforded by a low dose of CCl 4 ( L CCl 4 , 100 &mu;l/kg, ip) on the toxic effects of a subsequently administered moderately toxic dose of CCl 4 ( H CCl 4 , 2.5 ml/kg, ip) was established in male Sprague-Dawley rats. The protective dose provided 100% protection, whereas only 62.5% survival was observed when the corn oil vehicle was administered instead of the protective dose of L CCl 4 . Colchicine administration (1 mg/kg, ip in saline) 2 hr prior to the injection of L CCl 4 led to a complete loss of autoprotection resulting in 100% mortality in rats given the H CCl 4 . Earlier studies have established that colchicine selectively suppresses the early phase of hepatocellular regeneration at 6 hr without influencing the second phase at 36-48 hr. The consequence of colchicine antimitosis on the toxicological endpoints of liver injury was evaluated by serum enzyme elevations and by histopathological examination of the liver during a time course of 6, 24, 48, 72, and 96 hr after the administration of H CCl 4 . In the autoprotection regime, after only a transient and modest elevation of serum alanine and aspartate transaminases, complete recovery occurred by 96 hr. Hepatocellular necrosis was consistently lower compared to all other groups. Colchicine preadministration in the autoprotection regime resulted in significantly greater and progressive elevation of the serum enzymes and a correspondingly commensurate progression of hepatic lesion. Toxic effects of HCC14 alone were more rapidly and maximally augmented by colchicine preadministration. The role of hepatocellular regeneration in autoprotection was evaluated by 3 H-thymidine incorporation in hepatocellular nuclear DNA and by morphometric estimation of mitotic index. While H CCl 4 alone resulted in some stimulation of 3 H-thymidine incorporation and mitosis, the regenerative activity observed with prior L CCl 4 administration was remarkably greater, particularly at 48 hr. Colchicine preadministration in either of these 2 protocols decisively obtunded the stimulated regenerative activities essentially abolishing the tissue healing mechanisms. These results indicate that hepatocellular regeneration stimulated by the L CCl 4 not only enhances recovery from limited liver injury but also augments tissue repair process after massive liver injury is elicited by the subsequent H CCl 4 dose. Selective ablation of the early phase hepatocellular regeneration stimulated by the protective low dose of CCl 4 , by colchicine antimitosis, results in abolishment of CCl 4 autoprotection. Furthermore, in the absence of the early phase stimulation of tissue healing mechanisms, toxicity of a moderately toxic dose of CCl 4 is further augmented. These findings indicate the critical importance of the early stimulation of hepatocellular regeneration and tissue healing processes in the hepatotoxicity of CCl 4 .
A subtoxic dose of CCl 4 is known to destroy liver microsomal cytochrome P-450 and this is widely accepted as the mechanism of CCl 4 autoprotection. Circumstantial evidence suggests that while cytochrome P-450 is significantly decreased, this mechanism alone cannot explain the phenomenon of autoprotection. Previous studies have established that hepatocellular regeneration is stimulated as early as 6 hr after the administration of a low dose of CC14. If the early phase stimulation of hepatocellular regeneration by the protective dose is indeed the mechanism of autoprotection, then ablation of this early phase of tissue healing by colchicine should result in an abolishment of autoprotection. Present studies were conducted to test this conceptual premise. The protection afforded by a low dose of CCl 4 ( L CCl 4 , 100 &mu;l/kg, ip) on the toxic effects of a subsequently administered moderately toxic dose of CCl 4 ( H CCl 4 , 2.5 ml/kg, ip) was established in male Sprague-Dawley rats. The protective dose provided 100% protection, whereas only 62.5% survival was observed when the corn oil vehicle was administered instead of the protective dose of L CCl 4 . Colchicine administration (1 mg/kg, ip in saline) 2 hr prior to the injection of L CCl 4 led to a complete loss of autoprotection resulting in 100% mortality in rats given the H CCl 4 . Earlier studies have established that colchicine selectively suppresses the early phase of hepatocellular regeneration at 6 hr without influencing the second phase at [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] hr. The consequence of colchicine antimitosis on the toxicological endpoints of liver injury was evaluated by serum enzyme elevations and by histopathological examination of the liver during a time course of 6, 24, 48, 72, and 96 hr after the administration of H CCl 4 . In the autoprotection regime, after only a transient and modest elevation of serum alanine and aspartate transaminases, complete recovery occurred by 96 hr. Hepatocellular necrosis was consistently lower compared to all other groups. Colchicine preadministration in the autoprotection regime resulted in significantly greater and progressive elevation of the serum enzymes and a correspondingly commensurate progression of hepatic lesion. Toxic effects of HCC14 alone were more rapidly and maximally augmented by colchicine preadministration. The role of hepatocellular regeneration in autoprotection was evaluated by 3 H-thymidine incorporation in hepatocellular nuclear DNA and by morphometric estimation of mitotic index. While H CCl 4 alone resulted in some stimulation of 3 H-thymidine incorporation and mitosis, the regenerative activity observed with prior L CCl 4 administration was remarkably greater, particularly at 48 hr. Colchicine preadministration in either of these 2 protocols decisively obtunded the stimulated regenerative activities essentially abolishing the tissue healing mechanisms. These results indicate that hepatocellular regeneration stimulated by the L CCl 4 not only enhances recovery from limited liver injury but also augments tissue repair process after massive liver injury is elicited by the subsequent H CCl 4 dose. Selective ablation of the early phase hepatocellular regeneration stimulated by the protective low dose of CCl 4 , by colchicine antimitosis, results in abolishment of CCl 4 autoprotection. Furthermore, in the absence of the early phase stimulation of tissue healing mechanisms, toxicity of a moderately toxic dose of CCl 4 is further augmented. These findings indicate the critical importance of the early stimulation of hepatocellular regeneration and tissue healing processes in the hepatotoxicity of CCl 4 .
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INTRODUCTION
Autoprotection in simple terms can be defined as a phenomenon of protection afforded by a low dose of a toxic compound against the toxicity of a subsequently administered high dose of the same compound. The protection shown by a small dose of CCI, (LCCI,) against a high dose of CCI, (HCCI4) administered 24 hr later, is well known (5, 8, (37) (38) (39) . At present, the widely accepted mechanism for CCI, autoprotection is based on the destruction of CCI, bioactivation system by the low (protective) dose of CCl4 (2, 17, 30, 31, 33) . According to this concept, destruction of liver microsomal cytochrome P-450 by the protective dose of CCl4 presumably causes decreased bioactivation of subsequently administered H CCI4, which results in decreased toxicity (5, 17, 28) .
However, several lines of evidence from the study of chlordecone potentiated CCI, hepatotoxicity and lethality suggest that, CCI, autoprotection may not be due to decreased cytochrome P-450 content in the liver caused by the protective dose (4). Decreasing 60% of hepatic cytochrome P-450 content of both normal and chlordecone treated rats by treatment with CoCl2 did not result in any decrease in CCl4 toxicity (1) . Prior exposure to a small dose of CC14, which is known to decrease hepatic microsomal cytochrome P-450, failed to prevent chlordecone-potentiated CCI, hepatotoxicity and lethality (11) . While the hepatic cytochrome P-450 content was essentially the same in chlordecone pretreated partially hepatectomized (PH) rats 1 or 7 days post-PH, protection was observed only in the 1 and 2 day post-PH group (1) . Furthermore, studies on chlordecone-potentiated CCI, hepatotoxicity and lethality suggest that, suppressed early phase of hepatocellular regeneration ordinarily stimulated by a low dose ofCCl4 (1, 13-15, 19, 36) rather than decreased bioactivation (6, 10, 12, 21) is responsible for amplified toxicity. Liver regeneration and tissue repair are known to be stimulated in a biphasic manner during CCI,-induced liver injury (16, 18, 22, 23, 37) . Stimulation of hepatocellular regeneration by LCCI, leading to tissue repair and restoration of hepatolobular architecture not only allows the animal to overcome massive liver injury and toxicity caused by a subsequently administered HCCl4 but also induces resistance or autoprotection against toxic dose of CCl4 (37) . The present study was undertaken to investigate the role and importance of the early phase (6 hr) hepatocellular regeneration induced by LCCI~ (protective dose-100 ~1/kg, ip) in autoprotection against &dquo;CCl4 (2.5 ml/kg, ip). The early phase of LCCI4stimulated cell division could be decisively and selectively suppressed by using an antimitotic agent, colchicine (CLC; 1 mg/kg, ip) during CCI, autoprotection (25) . While CLC administered at this low dose is known to be effective in selective ablation of the early phase stimulation of mitosis by LCCl4 (25) , it is devoid of any adverse effects on hepatobiliary function (26) . CLC was administered to rats 2 hr prior to LCCI, (protective dose) or corn oil treatment and 24 hr later they were challenged with a toxic dose of CCl4 (HCCl4). Hepatotoxicity was assessed by serum alanine (ALT) and aspartate transaminase (AST), histopathology of liver including liver histomorphometry of necrotic, swollen and mitotic hepatocytes, and by following animal lethality. We report here a discrete experimental evidence implicating a role for the early phase of hepatocellular regeneration stimulated by the protective dose in augmenting the process of restoration of hepatolobular architecture, which permits recovery from liver injury seen equal in magnitude to that of rats not receiving the protective dose. A selective ablation of the early phase of hepatocellular regeneration and tissue healing by CLC antimitosis results in abrogation of this early liver tissue healing response, thereby permitting injury of the large dose of CC14 to permissively progress leading to animal death (36) .
MATERIALS AND METHODS

Animals
Male Sprague-Dawley rats (200-250 g) obtained from (Harlan Sprague-Dawley, Inc., Madison, WI) were maintained for 10 days on a 12 hr photoperiod in the central animal facility over untreated com cob bedding at 21°C ± 1 and 50-80% relative humidity. Water and Purina rat chow (Ralston Purina Chow #5001, Ralston Purina Co., St. Louis, MO) were available at all time ad libitum.
Chemicals
CCl4 was obtained from E. M. Science (Gibbstown, NJ), colchicine (Sigma Chemical Co., St. Louis, MO), and thymidine (methyl-3H, Sp activity 2 Ci/mmol) from New England Nuclear Corporation (Boston, MA).
Treatment
Groups of 8 rats were used for various treatments. LCCI, (100 >1/kg, ip) was administered in corn oil ( ml/kg). This low dose of CCl4 is known to be subtoxic (11, 12) . Either colchicine (CLC, 1 mg/kg, ip in saline) or saline ( ml/kg) was administered to rats 2 hr prior to the administration of corn oil or CCI, (25) . Through preliminary experiments, we established that a single administration of CLC (1 mg/ kg, ip) results in antimitosis against the early phase (6 hr) stimulation of hepatocellular regeneration in-TABLE L-Effect of colchicine on CCl4-induced mortality in rats.
LCCI,: Low dose CCI, (100 jul/kg, ip). HCCI,: High dose CCI, (2.5 ml/kg, ip). CLC: Colchicine. Rats were injected with CLC ( 1 mg/kg, ip in saline) 2 hr prior to I-CCI, or corn oil ( ml/kg, ip) administration. Twenty-four hr after '<'C1< administration, a single dose of HCCI, was administered. The rats were observed twice a day for 14 days and cumulative % mortality was recorded. Mortality observed at 120 hr was the same as that observed on day 14. duced by a low dose of CCI, without affecting the second phase (48 hr) significantly (25) . Also, it was established that this dose of CLC does not interfere with liver function at 6 or 24 hr after CLC injection (26) . Twenty-four hr after the corn oil or ~CCl~ treatment, a single high dose of CCI~ (~CCl4 2.5 ml/kg, ip in corn oil) was administered. At 6, 24, 48, 72, and 96 hr after ~CCl~ treatment, blood was collected from the dorsal aorta of rats under diethyl-ether anesthesia. The blood was used for measuring serum ALT and AST by the method of Reitman and Frankel (29), using Sigma kits 505-OP (Sigma Chemical Co., St. Louis, MO).
In Vivo Incorporation of 3H-Thymidine (3H-T)
into Rat Liver Nuclear DNA The procedure used is essentially that of Chang and Looney (3). The details of the procedure are the same as described earlier (36) .
Histopathology
For histopathology, liver sections were fixed in 10% formaldehyde embedded in paraffin wax and sectioned. The sections were stained with hematoxylin and eosine (H&E) for light microscopy. The number of mitotic figures in each section was estimated using the counting procedure of Weibel et al (40) . The details of the procedure are as described earlier (26, 36) .
Lethality
Groups of 8 rats were treated as indicated under treatment section. After treatment with either corn oil or CC'4 (LCC'4 and HCC14) to rats pretreated with either saline or CLC, they were observed for mortality up to 14 days and the cumulative mortalities were recorded. This experiment was conducted twice. The first experiment was designed as a feasibility study and to establish the autoprotection protocol. The second experiment was conducted to confirm the findings of the first experiment. Since the findings in both experiments were the same, the results were pooled and tabulated in Table I .
Statistics
The values in figures represent the mean of 8 rats.
Differences between any treatment group and its appropriate control were determined using Newman-Keuls test and Duncan multiple range test and p < 0.05 was considered significant.
RESULTS
Preliminary studies indicated that colchicine pretreatment ( 1 mg/kg, ip) given as a single dose results in a selective inhibition of the early phase stimulation of hepatocellular division observed after a low dose of CCI, (25) . In order to ascertain the role of early phase hepatocellular division induced by low dose of CC14 ( 100 >1/kg, ip) in autoprotection against toxic dose of CCl4 (2.5 ml/kg, ip), we assessed lethality, serum enzymes, liver histopathology, liver histomorphometry, and mitotic index in the livers of rats pretreated with or without colchicine. The outcome of this experiment is given below.
Lethality
Top two rows in Table I show the percentage mortality in CCI, autoprotection group as compared to the group which did not receive the protective low dose of CCl4 (LCCI4). One hundred percent survival was observed in autoprotection groups as compared to 62.5% survival in rats receiving only HCCI,.
The lower 2 rows in Table I show the influence of pretreatment with a single dose of CLC ( 1 mg/kg, ip). By 96 hr, 100% mortality was observed in animals regardless of whether a protective dose ofLCCl4 was administered. Therefore, treatment with CLC before the administration of the protective dose of CCI, abolished the protective effect entirely.
Serum Enzymes
The levels of serum ALT and AST are shown in Fig. 1 . CLC pretreated rats without the protective dose of CCI, showed a continuous and significant increase in serum enzymes on treatment with HCCI,, indicating greater liver injury. On the other hand, the rats treated with CLC + LCCI, showed signifi-
-Serum alanine (A) and aspartate (B) aminotransferase levels in rats pretreated with colchicine ( 1 mg/ kg, ip) or saline (1 ml/kg, ip) and 2 hr later either with com oil ( ml/kg, ip) or a low dose of CCl4 (LCCI4, 100 Allkg, ip). Twenty-four hr after LCCI, or com oil administration, a single dose of HCCI, (2.5 ml/kg, ip) was administered and the serum enzyme levels were measured at different time intervals after HCCl4 treatment. The treatment groups were: saline + corn oil + HCCI, (0); saline + LCCI, + HCCl4 (.); CLC + LCCI, + HCCI, (0); CLC + corn oil + HCCI, (ae!1). Values are mean ± SE for eight rats. *Significantly higher from saline + oil + HCCI4. **Significantly higher from saline + oil + HCCI4, saline + LCCI, + HCCI4. For the 3 groups (0,~,ae!1), data were derived from only the surviving animals (refer to Table  I ). cant increase in serum ALT levels at 48 hr as compared to the autoprotection group and the group receiving only HCC14. At 48 hr post HCC'4 treatment, the serum ALT levels were almost the same in autoprotection and HCC14 treated groups and they were significantly lower than CLC pretreated groups indicating progressive recovery from CC'4 toxicity.
However, serum AST levels remained continuously elevated up to 48 hr in autoprotection group as well as in CLC pretreated groups as compared to rats receiving HCC14 alone, indicating greater degree of hepatocellular damage. At 72 hr and thereatter, both the enzymes declined to proximately normal levels in all the experimental groups. It should be recalled that at 72 hr and thereafter, only surviving rats are represented for the serum enzyme data.
Liver Histopathology
Figs. 2 and 3 represent typical photomicrographs of livers from rats undergoing autoprotection protocol with or without CLC pretreatment. Fig. 2 represents 6 hr time point and Fig. 3 represents 48 hr time point after HCC14 treatment. Liver injury was revealed by the presence of necrotic and swollen (ballooned) hepatocytes (Figs. 2 and 3 ), which were quantitated by histomorphometry ( Fig. 4 ). Liver injury was evident as early as at 6 hr and was progressive through 24 hr in all of the groups. In rats receiving the protective dose of LCC14, liver injury was significantly lower (Fig. 4A ) than that observed at 24 hr in rats receiving only HCCl4.
Regardless of the protective dose OfL CC14, maximum liver injury was observed at 48 hr (Fig. 2) as evidenced by the presence of necrotic hepatocytes (Fig. 4 ). At later time points (72 and 96 hr), the liver injury began to decline indicating that tissue repair had taken place. It should be emphasized that the data for 48 hr and thereafter represent only the 62.5% surviving rats in the case of the group which did not receive LCC14 as the protective dose. At 48 hr and thereafter, the hepatic lesion in all of the rats receiving the protective dose (LCC14) and the surviving rats which did not receive the protective dose, showed restored hepatolobular tissue, indicating progressive recovery from injury.
Colchicine pretreatment resulted in equally progressive but greater liver injury regardless of whether the protective dose of LCC14 was administered ( Figs. 2 and 3 ). Hepatocellular necrosis was substantially higher at 24 hr (Fig. 4 ), but this increase was not evident at 6 hr ( Figs. 2 and 4) . The percentage of swollen (ballooned) cells was also remarkably higher in rats receiving the CLC treatment. Instead of recovery from liver injury, progression of injury was evident (Fig. 4 ) to a point of no return leading to animal death.
3H-Thymidine Incorporation in Hepatocellular
Nuclear DNA 3H-T incorporation during LCCl4 autoprotection against HCC14 and the effect of colchicine antimitosis are illustrated in Fig. 5 . In the absence of CLC pre- (2.5 ml/kg, ip) administration. The protocol followed for the experiment is the same as described in Fig. 1 . The treatment groups were: saline + corn oil + HCCl4 (0); saline + LCCI, + HCCl4 (A); CLC + '-CCl4 + HCCl4 (A); CLC + com oil + HCCI, (M). Values are mean ± SE for 8 rats. *Significantly higher compared to saline + com oil + HCC14, saline + LCCI, + HCCl4, CLC + LCCI, + HCCI4. **Significantly higher compared to saline + com oil + &dquo;CC1,, saline +'-CC14 + &dquo;CCl~. +Significantly higher compared to saline + LCCI, + HCCl4. For the 3 groups (0, A, M) the data were derived from only the surviving animals (refer to Table I) .
treatment, increased 3H-T incorporation was observed as early as 6 hr after HCCl4 treatment in the rats receiving the protective dose of LCCI,, with a significantly greater response at 48 hr and declining after 72 hr. In the rats receiving only HCCl4, progressive increase in 3H-T incorporation was observed starting from 24 hr and reached a maximum value at 72 hr in the 62.5% surviving animals (Fig.  5 ). On the other hand, CLC pretreatment led to significant suppression of 3H-T incorporation in rats regardless of whether they received the protective dose of LCCI¢, indicating lack of stimulation ofDNA synthesis.
Mitotic Index
Fig. 6 represents the mitotic index in the livers of rats showing autoprotection and those which did not show autoprotection either due to colchicine FIG. 5. -3H-thymidine incorporation in hepatic nuclear DNA at various time points after HCCI, (2.5 ml/kg, ip) administration. The details of the procedure are the same as described in Fig. 1 . The treatment groups were: saline + corn oil + HCCI, (0); saline + LCCI, + HCC14 (0); CLC + LCCI, + HCCI, (0); CLC + corn oil + HCCl4 «(Ij). Values are mean ± SE for 8 rats. *Significantly higher compared to saline + corn oil + HCC14, CLC + corn oil + HCCI,; **Significantly higher compared to saline + com oil + HCCl4, CLC + LCC14 + &dquo;CC1,, CLC + corn oil + &dquo;CC1,. +Significantly higher compared to saline + '-CC14 + HCC14, CLC + LCCl4 + &dquo;CCl~, CLC + corn oil + &dquo;CCL,. aSignificantly higher compared to saline + corn oil + HCCl4 treatment group at 6 hr. bSignificantly higher compared to saline + corn oil + HCCl4 treatment group at 6 and 24 hr. esignificantly higher compared to saline + com oil + HCCI, treatment group at 6, 24, and 72 hr. For the 3 groups {0, ~, IM), the data were derived from only the surviving animals (refer to Table I ). pretreatment or because they did not receive the protective dose before the injection of HCC14. The HCCl4 treatment did not stimulate mitotic activity in the livers up to 24 hr in any treatment group. At 48 hr post HCCl4-treatment, a significantly higher mitotic activity was observed in the livers of rats showing autoprotection. On the other hand, the rats receiving only HCCl4 exhibited a significant increase in mitotic activity in their livers at 72 and 96 hr in the 62.5% survivors. The response was found to be equal to that of autoprotection group (Fig. 6 ), indicating a higher tissue repair response, which presumably enabled the rats to overcome liver injury and toxicity. Colchicine pretreatment led to a significant suppression of liver mitotic activity regardless of whether they received the protective dose of LCCI4. The mitotic activity in the livers of rats showing autoprotection and those receiving HCCl4 alone was found to be 4-fold higher than observed in CLC pretreated groups (Fig. 6 ).
DISCUSSION
In the present study, in the group given LCCl4 followed by HCCl4, 100% of the rats survived at 48 FIG. 6. -Volume density of hepatocytes in mitosis at different time course after HCCI, (2.5 ml/kg, ip) administration. The details of the procedure are the same as explained earlier in Fig. 1 . The treatment groups were: saline + corn oil + HCCl4 (0); saline + LCC14 + HCC14 (a); CLC + '-CCl4 + &dquo;CC1, (A); CLC + corn oil + HCCI, (M). Values are the mean ± SE of 8 rats. *Significantly higher compared to CLC + '-CCl4 + HCCI4, CLC + corn oil + &dquo;CCl~. **Significantly higher compared to CLC + corn oil + H CC'4, CLC + '-CC14 + HCCl4, saline + corn oil + HCCI4. For the groups (0, ., E) the data were derived from only the surviving animals (refer to Table I ).
hr due to autoprotection (Table I) . A minimum time interval of 24 hr between the low-dose and the highdose treatment is required for maximum autoprotection (37) . The widely accepted mechanism for autoprotection is the destruction of liver microsomal cytochrome P-450 by the protective dose of CC14 (5, 8, 17, 38, 39) . Recent studies have shown that liver microsomal cytochrome P-450 content and associated enzymes, aminopyrine demethylase and aniline hydroxylase were found to be significantly decreased 24 hr after the protective dose of CCl44 (37). Glende (8) observed that the protective effect of low dose of CC14 is due to decreased microsomal enzyme activity, which lasts for 3 days. Dambrauskas and Cornish (5) reported that the rats showing autoprotection due to previous exposure to low dose of CCI, had consistently lower levels of CHCl3 in them than the rats receiving the same high dose of CC14 without the protective dose. These findings indicate that the rate of conversion of CCl¢ to CHCl3 was sufficiently decreased in autoprotected rats after exposure to the toxic dose of CC'4, an observation consistent with the widely accepted mechanism.
Although these data appear to be consistent with the widely accepted mechanism of CC'4 autoprotection, certain anomalies have been observed recently. Studies carried out recently by decreasing liver cytochrome P-450 content to 50% of the control by treatment with CoCl2 revealed that the hepatotoxicity of a large dose of CCl4 (5 ml/kg, po) given 24 hr later was not decreased (37) . Furthermore, despite a 50% destruction of cytochrome P-450 and associated enzyme activity by the protective dose of CC'4 (0.3 ml/kg, po), the liver injury from the subsequently administered large dose of CCl4 (5 ml/ kg, po) was not diminished in comparison to the injury inflicted by a large dose ofCCl4 by itself (37) . In the present study also liver injury of the high dose of CCI, was undiminished as evidenced by serum enzyme elevations, liver histopathology (Figs. 1 and 2) and hitomorphometric analysis of livers (Fig. 3 ) of rats receiving the protective dose. Nonetheless, there was 100% survival in the autoprotection group as revealed by the 14 day lethality study (Table I) .
A comparison of the liver histopathology and serum enzyme data during the entire time-course of study indicates that, the actual liver injury caused by high dose of CC'4 is not diminished by the prior exposure to low dose of CCI4. This suggests that there is sufficient amount of bioactivation of high dose of CCl4 in spite of the lower microsomal cytochrome P-450 content in the liver of autoprotected rats as shown earlier (8, 17, 27, 28, (37) (38) (39) . Moreover, Bell et al (1) have previously demonstrated that, hepatotoxicity of a high dose of CC'4 (2.5 ml/kg) was not diminished even after 60% decrease in hepatic microsomal cytochrome P-450 content brought about by COC'2 administration.
These results suggest that a mechanism other than destruction of cytochrome P-450 by the low dose of CCI, and events unrelated to the inflictive phase of CC'4 liver injury must be involved in the autoprotection phenomenon.
The mechanism that enables the animals to overcome such toxic liver injury is the hormetic response of the liver to injury which results in an augmentation of hepatocellular regeneration and tissue repair (20) . Administration of a low dose of CCl4 (100 1/kg) results in stimulation of hepatocellular regeneration in the form of mitosis, which occurs in 2 distinct phases: one as early as at 6 hr; and the second 48 hr (13, 14, 18) . In the present study, as expected, the low dose of CCl4 stimulated S-phase of cell cycle with an early-phase response at 2 hr and the second phase response at 48 hr as evidenced by 3H-T incorporation in hepatocellular nuclei (36) . These findings correspond well with the biphasic mitotic response at 6 and 48 hr (13, 14, 18, 36) .
With the availability of new and healthy cells, these events progressively lead to tissue healing, permitting a regression of liver injury, and restoration of normal hepatic functions. Earlier studies have shown that, the administration of a substantially greater toxic dose of CC'4 to rats receiving the protective dose of CCI, leads to a significantly stimulated hepatocellular regeneration at 48 hr (16. 24. 35) and a prompt recovery from toxic injury (37) . In the present study, administration of HCCl4 alone resulted in smaller increase in 3H-T incorporation at 48 hr, but a larger response at 72 and 96 hr ( Fig. 5 ) and significantly increased mitotic index (Fig. 6 ) in the 62.5% surviving animals was observed, indicating the importance of hepatocellular regeneration and tissue healing mechanisms that enable the liver to overcome toxicity. Upon administration of a toxic dose of CCI, (HCCl4) to the rats receiving the protective dose of CC14 (LCCI,) even though the second wave of cellular regeneration is delayed by additional 24 hr, it appears with a much larger response as evidenced by 3H-T incorporation (Fig. 5 ) and a correspondingly increased mitotic index (Fig.  6 ) are able to more than compensate for this delay. The delay in the onset of the mitotic activity observed in animals receiving HCCI, after the LCCI, in comparison to those receiving only LCC14, is presumably due to the toxicity associated with the administration of HCCl4. Nonetheless, because the events necessary for stimulated hepatocellular regeneration have been already initiated by the LCCI,, a much greater mitotic response is observed subsequent to this initial lag period. These observations clearly indicate the significant contribution of hepatocellular regeneration to recovery from the massive liver injury, which is ultimately reflected as autoprotection.
Colchicine pretreatment leads to a significant suppression of hepatocellular regeneration stimulus as evidenced by decreased 3H-T incorporation at early time point in low dose CCI, treated rats (25) and complete suppression after HCCI, treatment (Fig. 5) which is consistent with decreased mitotic index ( Fig. 6 ). This is a clear indication of the fact that the augmented HCCl4 toxicity and lethality in CLC pretreated rats is due to failure in hepatocellular regeneration and lack of tissue healing mechanism.
Moreover, colchicine pretreatment leads to prolongation of LCCI, toxicity, as evidenced by increased prevalence of necrotic and swollen (ballooned) hepatocytes at 24 to 48 hr after LCCI, treatment (25) . In the present study, the rats receiving CLC + LCCI, showed remarkably higher percentage of swollen hepatocytes at early time points (6 and 24 hr, Fig. 2 ) after treatment with HCCl4 as compared to the rats receiving only HCCI,, LCCI, + HCCI, (autoprotected) and those receiving CLC + oil. This is presumably due to the reflagration of the low level liver injury caused by LCCl4 (25) upon the administration of HCCI, 24 hr later. Increased hepatocellular necrosis at later time points (e.g., 48 hr) in colchicine pretreated rats might prompt one to look for the possibility of increased bioactivation of CCI, in these rats as a plausible explanation of pro-longed and greater toxicity. From our previous study, it is evident that colchicine does not enhance CCl4 metabolism, but does cause a significant antimitotic effect at 6 hr after the administration of a low dose of CCI4. Whereas only low dose CCI, treated rats had very high percentage of mitotic figures at 6 hr, which is effectively blocked in rats treated with CLC, the second phase hepatocellular regeneration normally occurring at 48 hr after low dose CCI, administration was not significantly blocked in colchicine pretreated rats (18, 25) . While the effect of colchicine ( mg/kg, ip) is not long lasting, it is quite sufficient enough to selectively block the early event of hepatocellular regeneration without causing any hepatobiliary dysfunction (25, 26) . If one compares the autoprotection group with the group receiving only HCCI, and the CLC pretreated (non-autoprotected) rats with regard to serum enzymes, 3H-T incorporation, and mitotic index at 48 hr, it is clear that the protective dose (LCCI,) augmentation of the tissue repair and restoration mechanism at early time point of 2-6 hr (25, 37) plays a critical role in recovery from liver injury leading to autoprotection.
The decline in serum enzyme levels at 72 hr (Fig.  1 ) in the rats receiving HCCI, alone, represents only the surviving animals. With regard to the HCCl4 treated rats, it is evident from 3H-T incorporation studies (Fig. 5 ) and miotic index (Fig. 6 ) that, there was significant stimulation of both events at 72 hr, which led to recovery from liver injury reflected by the decline in serum enzymes. On the other hand, in the colchicine pretreated group, the liver injury was progressive (Figs. [2] [3] [4] , presumably due to lack of hepatocellular regeneration (Figs. 5 and 6), and hence, due to lack of a mechanism to check the progression of liver injury. An interesting observation associated with CLC treatment is worthy of mention. In spite of massive liver injury in CLC pretreated animals, the serum enzyme levels declined at 72 hr, which is supposedly due to disruption of enzyme synthesizing apparatus by toxic dose of CCI, (32, 33) in the absence of hepatocellular regeneration and repair mechanisms. This supposition is supported by previous reports. Gravela and Dianzani (9) and Dianzani (7) reported polysome disaggregation following CCl4 exposure in vivo. Since CLC pretreatment leads to progressive toxicity in contrast to the HCCl4 or LCCI, + HCC14 treatments, it is possible that there is no rejuvenation of enzyme synthesizing machinery, hence the serum enzyme levels remain low in spite of high degree of liver toxicity and lethality in the CLC pretreated groups.
In conclusion, these findings implicate a pivotal role for hepatocellular regeneration and tissue healing mechanisms stimulated by the protective dose in the mechanism of autoprotection. The prevailing concept of decreased bioactivation of the toxic dose of CCl4 owing to decreased cytochrome P-450 cannot be supported by direct end-points of liver injury measured in this study. Early augmentation of hepatocellular regeneration and tissue repair evoked by the administration of low dose of CCI, appears to permit timely recovery and restoration of hepatic structure and function. In the absence of the protective dose, hepatocellular regeneration is substantially deficient and it occurs too late (13, 14) to tip the delicate balance between recovery and progression of massive injury in favor of recovery (20) . Suppression of the early phase of hepatocellular regeneration and tissue repair induced by LCC14, by prior treatment with colchicine, leads to complete failure in recovery from toxic liver injury, leading to a high rate of mortality. These findings provide discrete evidence to suggest a critical and mechanistic role played by the protective dose-stimulated hepatocellular regeneration and tissue repair in the autoprotection phenomenon.
